CD4 and neoplasm: To determine which types of immune cells are activated by B002T‐LP004 during tumor rejection and, thus, which types of immune cells play a more important role in tumor rejection, we first cleared CD4+ T, CD8+ T, and NK cells and macrophages from C57BL/6jGpt mice bearing Mc38‐hHER2 individually.